Navigation Links
Challenges in Prostate Cancer Screening by Prostate Cancer Antigen

Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America.

A recent nation-wide survey indicates almost half of Canadian men over 50 years old are tested during their lifetime. In this review, Drs. Ian Thompson and Donna Ankerst examine the evidence in support of the blood test and then discuss how physicians should advise patients about the merits and drawbacks of the test.

In a related commentary, Dr. Michael Jewett and colleagues examine the evidence from two large studies indicating that the drug finasteride is beneficial in reducing both the size of enlarged prostate glands and the risk of prostate cancer.




'"/>




Page: 1

Related medicine news :

1. Australia Ready to Meet the Challenges of Bird Flu
2. Sexual Health Service Is Under Pressure and Faced With Financial Challenges
3. Abuja Challenges the Government
4. Nurses in South Africa Face Challenges
5. Bangladesh Progressing But Must Yet Face Challenges In Health Sector
6. Fresh Water, HIV Biggest of Indias Six Challenges: Chidambaram
7. New Study Challenges How Regulators Determine Risk
8. FDA Cites Challenges of Generic Biotech
9. Study Challenges Conventional Treatment of Traumatic Brain Injury
10. Challenges in Entecavir Drug Treatment
11. Cancer Doctors Okays Controversial Prostate Therapy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Bionic Sports ... all walks of life, announced it had a successful January ECRM Trade Show in ... in the United States, which allows it to provide its products to all clients ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... products to enhance people’s everyday lives, recently attended the January ECRM Trade Show ... ATP Science is known for its large range of supplements that keep the ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Michael and ... Dana Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as ... has not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... and its sugar-free alternative VW+ 002. The drinks have been produced in collaboration ... conditions to perform during your workout. , After a successful launch in Sweden ...
(Date:1/20/2017)... ... 2017 , ... “The Angel”: a heartwarming and earnest tale of faith ... his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former ... impassioned writer. , When asked of her new book, Marjorie says, “‘The Angel’ was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Accuray Incorporated ... CyberKnife® and TomoTherapy® Systems continue to set the bar ... the highest composite overall user satisfaction rating among radiation ... Q4 2016 MD Buyline Market Intelligence Briefing™. The most ... highest composite ratings among industry peers for 11 of ...
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. (Nasdaq: ... federal institution supporting research in Germany ... patient treatments at the University Clinic Heidelberg as part ... The MRIdian Linac program will be headed by Medical ... heads radiation oncology at the German Cancer Research Center ...
(Date:1/19/2017)... January 19, 2017 New ... to Address Motor Symptoms and Motor Complications in ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
Breaking Medicine Technology: